Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Issues in the inhalation toxicity testing and hazard assessment for low density particulate materials such as synthetic amorphous silica (SAS)" [Toxicol. Lett. (in press)].
Dekant W, Antoniou EE, Bosch A, Bruer GG, Colnot T, Creutzenberg O, Drexel CP, Duffin R, Krueger N, Nolde J, Poland C, Schaudien D, Schuster TB, Stintz M, Weber K, Wessely B, Zeegers MP. Dekant W, et al. Among authors: bosch a. Toxicol Lett. 2023 Aug 15;385:29-30. doi: 10.1016/j.toxlet.2023.08.010. Epub 2023 Aug 31. Toxicol Lett. 2023. PMID: 37659256 Free article. No abstract available.
Issues in the inhalation toxicity testing and hazard assessment for low density particulate materials such as synthetic amorphous silica (SAS).
Dekant W, Antoniou EE, Bosch A, Bruer GG, Colnot T, Creutzenberg O, Drexel CP, Duffin R, Krueger N, Nolde J, Poland C, Schaudien D, Schuster TB, Stintz M, Weber K, Wessely B, Zeegers MP. Dekant W, et al. Among authors: bosch a. Toxicol Lett. 2024 Aug;399 Suppl 1:2-11. doi: 10.1016/j.toxlet.2023.02.002. Epub 2023 Feb 16. Toxicol Lett. 2024. PMID: 36806657 Free article. Review.
National Cohort of Compassionate Use of Meropenem-Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa.
Dinh A, Bleibtreu A, Duran C, Bouchand F, Bosch A, Crozon-Clauzel J, Roncato-Saberan M, Matt M, Boibieux A, Fanton A, Wille H, Fiaux E, Pilmis B, Lacoste M, Saint-Genis Q, Thumerelle C, Pavese P, Vuotto F, Senneville E, Potron A, Corvec S, Boutoille D, Jeannot K, Dortet L, On Behalf Of The Meropenem-Vaborbactam French Study Group. Dinh A, et al. Among authors: bosch a. Antibiotics (Basel). 2024 Dec 1;13(12):1152. doi: 10.3390/antibiotics13121152. Antibiotics (Basel). 2024. PMID: 39766541 Free PMC article.
1,151 results